Montage (688008) Report Interpretation
Management expects newer DDR5 interface chips to improve product mix despite near-term pricing pressure, while PCIe and CXL products add future revenue sources. Goldman Sachs retains Buy with 12-month targets of Rmb380.00 for the A-share and HK$572.00 for the H-share.
Summary
Management expects newer DDR5 interface chips to improve product mix despite near-term pricing pressure, while PCIe and CXL products add future revenue sources. Goldman Sachs retains Buy with 12-month targets of Rmb380.00 for the A-share and HK$572.00 for the H-share.
- DDR5 Gen 3 and Gen 4 RCD chips became the main revenue contributors in 1H26.
- DDR5 Gen 5 has entered volume production, while Gen 6 9,200 MT/s RCD chips are in sampling.
- PCIe 6.x retimers have launched; PCIe switch chips are targeted for tape-out by end-2026E.
- CXL 3.2 MXC chip trial production began in July 2026.
- Goldman Sachs sees product-mix improvement and multiple new-product revenue streams supporting growth and profitability.
Report Interpretation
Overview
This conference takeaway summarizes Montage management’s comments on DDR5 interface-IC upgrades, new AI interconnect products and margins. Goldman Sachs remains positive on the company’s memory interconnect position and expanding product portfolio, and maintains Buy.
Core views
Montage’s DDR5 interface-IC transition is the central near-term growth driver. Management said DDR5 Gen 3 and Gen 4 RCD chips had become the major revenue contributors in 1H26, Gen 5 products had begun volume production, and Gen 6 RCD chips offering 9,200 MT/s were in sampling. Goldman Sachs views the migration to newer DDR5 generations as a product-mix upgrade that can support growth and improved profitability, even though management acknowledged near-term pricing pressure. The company also expects MRCD/MDB solutions to ramp gradually as customers seek higher memory bandwidth. The report identifies a widening AI interconnect product pipeline beyond DDR5. Montage launched PCIe 6.x retimers in 2026 and is conducting R&D for PCIe 7.0. PCIe switch chips are targeted for tape-out by the end of 2026E, while first trial production of the CXL 3.2 MXC chip began in July 2026 alongside an expanding ecosystem. Goldman Sachs expects PCIe retimers, CKD chips and the developing PCIe switch and CXL MXC offerings to make rising revenue contributions over time. Its positive view rests on Montage’s leading position in memory interconnect ICs and the prospect of incremental revenue from several new products. For valuation, Goldman Sachs sets a 12-month A-share target of Rmb380.00, based on 48.1x 2030E discounted P/E. The target multiple is derived from the relationship between peers’ P/E multiples and net-income growth. The H-share target is HK$572.00, based on 66.4x 2030E P/E, representing a 38% valuation premium to the A-share and using a CNY/HKD rate of 1.09. At prices of Rmb213.00 for the A-share and HK$285.00 for the H-share as of 28 August 2026, the stated upside is 78.4% and 100.7%, respectively. Goldman Sachs maintains Buy.
Analysis framework
Goldman Sachs uses management discussion from its Asia Leaders Conference to assess product-generation progress, new-product milestones, expected mix effects and margin considerations. It then values the shares using a discounted forward P/E approach calibrated to peers’ P/E and net-income-growth relationship.
Methodology notes
Discounted forward P/E valuation calibrated using peers’ P/E and net-income-growth correlation.
The report applies a 48.1x 2030E discounted P/E to the A-share and a 66.4x 2030E P/E to the H-share; the multiple selection is linked to how peer valuations relate to net-income growth.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Montage (A) (688008.SS)Primary covered A-share; expected to benefit from DDR5 upgrades and expanding AI interconnect products.
- Strengths
- Leading position in memory interconnect ICs; Gen 3/4 DDR5 RCD chips were major revenue contributors in 1H26; Gen 5 volume production has started.
- Weaknesses
- Near-term pricing pressure.
- Comparison
- A-share target is based on 48.1x 2030E discounted P/E; the H-share target carries a 38% valuation premium.
- Risks
- Weaker memory interface-IC market growth, slower new-product introductions, or fiercer competition.
- Montage (H) (6809.HK)Primary covered H-share representing the same product and growth thesis.
- Strengths
- Exposure to Montage’s DDR5, PCIe and CXL MXC product expansion.
- Weaknesses
- Near-term pricing pressure.
- Comparison
- Target of HK$572.00 is based on 66.4x 2030E P/E and a 38% premium to the A-share valuation.
- Risks
- Weaker memory interface-IC market growth, slower new-product introductions, or fiercer competition.
Key data
- A-share 12-month target priceRmb380.00Based on 48.1x 2030E discounted P/E; versus Rmb213.00 price as of 28 August 2026.
- H-share 12-month target priceHK$572.00Based on 66.4x 2030E P/E, a 38% premium to the A-share valuation, using 1.09 CNY/HKD.
- Stated upside78.4% for A-share; 100.7% for H-shareCalculated from the reported prices and 12-month targets.
- DDR5 Gen 6 RCD speed9,200 MT/sProducts were in the sampling stage.
- CXL 3.2 MXC chipFirst trial production started in July 2026Management cited an expanding ecosystem.
- PCIe switch chipsTape-out targeted by end-2026EPart of the new AI interconnect product pipeline.
- Revenue forecastRmb8,106.2mn in 2026E; Rmb11,120.8mn in 2027E; Rmb15,567.1mn in 2028EGoldman Sachs forecasts.
- EPS forecastRmb3.44 in 2026E; Rmb4.26 in 2027E; Rmb5.78 in 2028EGoldman Sachs forecasts.
Impact & implications
The report argues that newer DDR5 products should improve Montage’s mix and profitability while PCIe and CXL offerings broaden its AI interconnect opportunity. The expected contribution from multiple new products underpins Goldman Sachs’ continued Buy rating.
Risks
- Memory interface-IC market growth could be weaker than Goldman Sachs expects.
- New-product introductions could progress more slowly than expected.
- Market competition could become fiercer than expected.
What to watch
- Ramp-up progress for DDR5 Gen 5 products and sampling progress for Gen 6 9,200 MT/s RCD chips.
- The pace of MRCD/MDB solution adoption as higher memory bandwidth is required.
- PCIe switch-chip tape-out targeted by end-2026E.
- Development of the CXL 3.2 MXC chip following trial production that began in July 2026.
- The extent of near-term pricing pressure and its effect on margins.